Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Oxid Med Cell Longev ; 2018: 7820890, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29849914

RESUMO

Statins are 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, and this class of drugs has been studied as protective agents against DNA damages. Alkylating agents (AAs) are able to induce alkylation in macromolecules, causing DNA damage, as DNA methylation. Our objective was to evaluate atorvastatin (AVA) antimutagenic, cytoprotective, and antigenotoxic potentials against DNA lesions caused by AA. AVA chemopreventive ability was evaluated using antimutagenicity assays (Salmonella/microsome assay), cytotoxicity, cell cycle, and genotoxicity assays in HepG2 cells. The cells were cotreated with AVA and the AA methyl methanesulfonate (MMS) or cyclophosphamide (CPA). Our datum showed that AVA reduces the alkylation-mediated DNA damage in different in vitro experimental models. Cytoprotection of AVA at low doses (0.1-1.0 µM) was observed after 24 h of cotreatment with MMS or CPA at their LC50, causing an increase in HepG2 survival rates. After all, AVA at 10 µM and 25 µM had decreased effect in micronucleus formation in HepG2 cells and restored cell cycle alterations induced by MMS and CPA. This study supports the hypothesis that statins can be chemopreventive agents, acting as antimutagenic, antigenotoxic, and cytoprotective components, specifically against alkylating agents of DNA.


Assuntos
Atorvastatina/farmacologia , Ciclofosfamida/farmacologia , Dano ao DNA/efeitos dos fármacos , Regulação para Baixo/efeitos dos fármacos , Metanossulfonato de Metila/farmacologia , Alquilantes/química , Alquilantes/farmacologia , Alquilação , Atorvastatina/química , Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Núcleo Celular/química , Núcleo Celular/efeitos dos fármacos , Ciclofosfamida/química , Células Hep G2 , Humanos , Metanossulfonato de Metila/química , Salmonella enterica/efeitos dos fármacos , Salmonella enterica/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA